BSPA Stock Ballston Spa Ban (BSPA, $70.62) was a top quarterly gainer, rising +15.44%

GET DAILY SIGNALS

Get AI intraday signals

BSPA - Ballston Spa Bancorp, Inc.

Loading...

Price: $70.62

Daily change: +$2.41 (+3.53%)

Daily volume: 320

3-month price change: +$9.4463 (+15.44%)

Capitalization: $52.4M

Industry: Regional Banks

Ballston Spa Ban (BSPA, $70.62) was one of top quarterly gainers, jumping +1 to $70.62 per share. A.I.dvisor analyzed 880 stocks in the Regional Banks Industry over the last three months, and discovered that of them (8) charted an Uptrend while of them (1) trended down.

Momentum Indicator for BSPA turns positive, indicating new upward trend

BSPA saw its Momentum Indicator move above the 0 level on December 19, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator turned positive. In of the 29 cases, the stock moved higher in the following days. The odds of a move higher are at .

Technical Analysis (Indicators)

Bullish Trend Analysis

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for BSPA entered a downward trend on January 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 54, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.738) is normal, around the industry mean (1.179). P/E Ratio (9.627) is within average values for comparable stocks, (18.370). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.246). Dividend Yield (0.019) settles around the average of (0.035) among similar stocks. P/S Ratio (1.766) is also within normal values, averaging (5.364).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BSPA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.